This content is machine translated Findings from the SUSTAIN-6 study GLP-1RA with cardiovascular benefits in the treatment of type 2 diabetes In the context of prevalent type 2 diabetes (T2D) worldwide and associated comorbid cardiovascular disease, the results of the SUSTAIN-6 trial add to the accumulating evidence of robust cardiovascular risk…
